Literature DB >> 25791243

Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.

Linus Angenendt1, Andrea Kerkhoff, Stefanie Wiebe, Jan-Henrik Mikesch, Annika Rudat, Fabian Wötzel, Christian Wenning, Christoph Schliemann, Torsten Kessler, Michael Schäfers, Eva Wardelmann, Matthias Stelljes, Wolfgang E Berdel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25791243     DOI： 10.1007/s00277-015-2353-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; David Wu; Aaron Goodman; Raymond Wong; Amy Chadburn; Sunita Nasta; Gordan Srkalovic; Sudipto Mukherjee; Heather Leitch; Raj Jayanthan; Simone Ferrero; Yasuharu Sato; Steve Schey; Angela Dispenzieri; Eric Oksenhendler; Pier Luigi Zinzani; Mary Jo Lechowicz; Christian Hoffmann; Naveen Pemmaraju; Adam Bagg; Alexander Fossa; Megan S Lim; Frits van Rhee
Journal:  Am J Hematol       Date:  2020-09-25       Impact factor: 13.265

2.  Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.

Authors:  Sisi Cai; Zhaodong Zhong; Xiang Li; Hong Xiang Wang; Li Wang; Min Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 3.  A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation for HHV8-Positive Castleman's Disease with a Review of the Literature.

Authors:  Zhen Wang; Shiwei Yang; Zunmin Zhu; Pingchong Lei; Jing Yang; Ping Zhang; Kai Sun
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

4.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.